In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The health of Arvind Kejriwal, lodged in Tihar Jail, is not good. It is being told from Aam Aadmi
Shiv Sena is continuously attacking stand-up comedian Kunal Kamra. Angered by the 'traitor' state
Shah Rukh Khan Film Jawan Preview Out: Shah Rukh Khan's fans are eagerly waiting for his next fil
Former Pakistan Prime Minister Imran Khan has claimed that the conspiracy to kill him was hatched
There has been an increase in the cases of corona in India (Covid 19 Cases). A day later, more th
Former MP Sanjay Nirupam on Thursday took a dig at the Congress leadership over his expulsion fro
Asia's richest man Gautam Adani has completed the acquisition of cement company Ambuja and ACC. G
People from all over the country and the world gathered for the Mahasnan of Mahakumbh in Tirthara
The National Testing Agency (NTA) has released the results of the Joint Entrance E
SC: Judges differ in the hijab ban case, case was sent to Chief Justice, the larger bench will hear
The Supreme Court on Thursday delivered its verdict on various petitions challenging the Karnatak
